agilon health, inc. (AGL)
$
2.23
-0.12 (-5.38%)
Key metrics
Financial statements
Free cash flow per share
-0.1470
Market cap
972.8 Million
Price to sales ratio
0.1624
Debt to equity
0.0840
Current ratio
1.2008
Income quality
0.1671
Average inventory
0
ROE
-0.4355
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Agilon Health, Inc. specializes in providing healthcare services for seniors in communities across the United States through primary care physicians. As of December 31, 2021, the company served approximately 238,000 senior members, which included 186,300 Medicare Advantage members and 51,700 Medicare fee-for-service beneficiaries. The company recorded an operating income of -$292,130,000.00 reflecting its earnings from core operations. Additionally, the total costs and expenses for the company are $6,352,660,000.00 reflecting its overall spending. The net total of other income and expenses is $43,304,000.00 reflecting non-core financial activities. The EBITDA is -$218,186,000.00 a key indicator of the company's operational profitability. Furthermore, the weighted average number of diluted shares outstanding is $410,966,000.00 reflecting potential dilution effects. Agilon Health, Inc., which was formerly known as Agilon Health Topco, Inc. until March 2021, was founded in 2016 and is based in Austin, Texas. In the financial market, the stock is affordable at $2.35 making it suitable for budget-conscious investors. Furthermore, the stock has a high average trading volume of $5,919,469.00 indicating strong liquidity. With a market capitalization of $923,112,960.00 the company is classified as a small-cap player, which can provide unique opportunities for growth. It is a key player in the $Medical - Care Facilities industry, contributing significantly to the overall market landscape. Moreover, it belongs to the $Healthcare sector, driving innovation and growth within its market niche. Together, these attributes highlight the company's standing and potential for investors seeking involvement in the healthcare sector focused on senior care.
Investing in agilon health, inc. (AGL) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C-, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict agilon health, inc. stock to fluctuate between $1.50 (low) and $7.73 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-05-29, agilon health, inc.'s market cap is $923,112,960, based on 413,952,000 outstanding shares.
Compared to Meta Platforms, Inc. Class A Common Stock, agilon health, inc. has a Lower Market-Cap, indicating a difference in performance.
agilon health, inc. pays dividends. The current dividend yield is 5.81%, with a payout of $0.45 per share.
To buy agilon health, inc. (AGL) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AGL. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Revenue: $6,060,530,000 | EPS: -$0.63 | Growth: -1.56%.
Visit https://agilonhealth.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $44.83 (2021-06-18) | All-time low: $1.50 (2024-11-18).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
agilon health, inc. (NYSE:AGL ) Q1 2025 Results Conference Call May 6, 2025 4:30 PM ET Company Participants Evan Smith - Senior Vice President of Investor Relations Steve Sell - Chief Executive Officer Jeff Schwaneke - Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Elizabeth Anderson - Evercore ISI Jailendra Singh - Truist Securities Justin Lake - Wolfe Research Amir Farahani - Bernstein Lisa Gill - JPMorgan Ryan Langston - TD Cowen Joanna Gajuk - Bank of America Ryan Daniels - William Blair Michael Ha - Baird Matthew Shea - Needham Daniel Grosslight - Citi Jenny Shen - BTIG George Hill - Deutsche Bank Whit Mayo - Leerink Partners Thomas Walsh - Barclays Operator Hello, everybody, and welcome to the agilon health First Quarter 2025 Earnings Conference Call.
zacks.com
Agilon Health (AGL) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.01 per share a year ago.
seekingalpha.com
agilon health's stock has surged over 165% YTD in 2025 despite a 77% decline since its 2021 IPO, driven by CMS rate hikes for 2026. The company faces challenges with significant operating losses and industry headwinds, but remains committed to value-based care over fee-for-service models. agilon's business model involves global capitation fees from health plan payors, focusing on Medicare Advantage through a network of physician partners.
zacks.com
Agilon (AGL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
businesswire.com
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the BofA Securities 2025 Health Care Conference including a fireside chat presentation on Wednesday, May 14 at 1:00 PM Eastern Time. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the “Events & Presentations” section of agilon health's inve.
zacks.com
Here is how Agilon Health (AGL) and Paragon 28, Inc. (FNA) have performed compared to their sector so far this year.
benzinga.com
J.P. Morgan analyst Lisa C. Gill, with a Neutral rating, updated estimates for Agilon Health, Inc. AGL following fourth-quarter results posted last month.
zacks.com
Here is how Agilon Health (AGL) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year.
seekingalpha.com
agilon health, inc. (NYSE:AGL ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Evan Smith - Senior Vice President of Investor Relations Steven Sell - Chief Executive Officer Jeffrey Schwaneke - Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Justin Lake - Wolfe Research Jack Slevin - Jefferies Ryan Langston - TD Cowen Amir Farahani - Bernstein Jailendra Singh - Truist Securities Michael Ha - Baird Elizabeth Anderson - Evercore Adam Ron - Bank of America Ryan Daniels - William Blair Whit Mayo - Leerink Partners Daniel Grosslight - Citi David Larsen - BTIG George Hill - Deutsche Bank Matt Shea - Needham Operator Hello and welcome to the agilon health Fourth Quarter 2024 Earnings Conference.
zacks.com
While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
See all news